Teladoc, Inc. (NYSE:TDOC) VP Mark Hirschhorn sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, September 22nd. The stock was sold at an average price of $31.93, for a total value of $798,250.00. Following the transaction, the vice president now directly owns 64,987 shares in the company, valued at $2,075,034.91. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Teladoc (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, August 2nd. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The firm had revenue of $44.60 million during the quarter, compared to analysts’ expectations of $44.39 million. During the same quarter in the previous year, the firm earned ($0.38) earnings per share. Teladoc’s revenue was up 68.3% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: “Insider Selling: Teladoc, Inc. (TDOC) VP Sells 25,000 Shares of Stock” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/insider-selling-teladoc-inc-tdoc-vp-sells-25000-shares-of-stock/1587681.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. ETF Managers Group LLC purchased a new position in Teladoc in the 2nd quarter worth approximately $104,000. Great West Life Assurance Co. Can purchased a new position in Teladoc in the 1st quarter worth approximately $105,000. US Bancorp DE raised its holdings in Teladoc by 10.3% in the 1st quarter. US Bancorp DE now owns 4,617 shares of the health services provider’s stock worth $116,000 after acquiring an additional 433 shares during the last quarter. Bank of Montreal Can raised its holdings in Teladoc by 214.2% in the 2nd quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock worth $123,000 after acquiring an additional 2,397 shares during the last quarter. Finally, Pacad Investment Ltd. purchased a new position in Teladoc in the 2nd quarter worth approximately $135,000.

TDOC has been the subject of a number of recent research reports. Canaccord Genuity reissued a “buy” rating and set a $42.00 price objective (up from $34.00) on shares of Teladoc in a report on Tuesday, June 20th. Chardan Capital boosted their price objective on Teladoc from $30.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, June 20th. Piper Jaffray Companies reissued a “buy” rating and set a $32.00 price objective on shares of Teladoc in a report on Friday, July 14th. KeyCorp reissued a “buy” rating and set a $37.00 price objective on shares of Teladoc in a report on Sunday, September 17th. Finally, TheStreet lowered Teladoc from a “c-” rating to a “d” rating in a report on Monday, July 3rd. Five investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Teladoc presently has a consensus rating of “Buy” and an average price target of $35.82.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Insider Buying and Selling by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.